Predominant emphysema phenotype in chronic obstructive pulmonary disease patients

European Respiratory Journal

Volumn 21, Issue 3, 2003, Pages 450-454

  Boschetto, P ^a   Miniati, M ^b   Miotto, D ^a   Braccioni, F ^a   De Rosa, E ^a   Bononi, I ^a   Papi, A ^a   Saetta, M ^d   Fabbri, L M ^c   Mapp, C E ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Computed tomography; Emphysema

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CARBON MONOXIDE; LONG ACTING DRUG; STEROID; THEOPHYLLINE;

AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DIFFUSION; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG FUNCTION TEST; LYMPHOCYTE COUNT; MALE; OUTPATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; SCORING SYSTEM; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; VITAL CAPACITY;

EID: 0347296336     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00048703     Document Type: Article

References (30)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-S121.
2. Pauwels RA, Buist AS Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
3. Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309-1314.
4. Thurlbeck WM, Muller NL. Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol 1994; 163: 1017-1025.
5. Peleman RA, Rytila PH, Kips JC, Joos GF, Pauwels RA. The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 839-843.
6. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-280.
7. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1773-1777.
8. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8: 1398-1420.
9. Miniati M, Filippi E, Falaschi F, et al. Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease. Chest radiography versus high resolution computed tomography. Am J Respir Crit Care Med 1995; 151: 1359-1367.
10. Quanjer PhH, Tammeling GJ, Cotes JE, Pederson OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: Suppl. 16, 5-40.
11. Cotes JE, Chinn DJ, Quanjer PhH, Roca J, Yernault J-C. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 1993; 6: Suppl. 16, 41-52.
12. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J 1997; 10: 1683-1693.
13. Milne ENC, Pistolesi M. Detecting and quantifying chronic bronchitis and emphysema. In: Milne ENC, Pistolesi M, eds. Reading the Chest Radiograph. A Physiologic Approach. Mosby, St. Louis, 1993; pp. 267-310.
14. Sakai F, Gamsu G, Im JG, Ray CS. Pulmonary function abnormalities in patients with CT-determined emphysema. J Comput Assist Tomogr 1987; 11: 963-968.
15. Rytila PH, Lindqvist AE, Laitinen LA. Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 1116-1119.
16. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 1982; 143: 29-36.
17. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
18. Coxson HO, Rogers RM, Whittall KP, et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 1999; 159: 851-856.
19. Park KJ, Bergin CJ, Clausen JL. Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology 1999; 211: 541-547.
20. Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS. The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet 1966; 1: 830-835.
21. Zompatori M, Fasano L, Battista G, Pacilli AM, Stopazzoni C, Cavina M. Role of emphysema in the etiology of functional impairment in patients with severe chronic obstructive pulmonary disease. Study with high resolution computerized tomography. Radiol Med (Turin) 1999; 97: 26-32.
22. Mitchell RS, Stanford RE, Johnson JM, Silvers GW, Dart G, George MS. The morphologic features of the bronchi, bronchioles, and alveoli in chronic airway obstruction: a clinicopathologic study. Am Rev Respir Dis 1976; 114: 137-145.
23. Fletcher CM, Jones NL, Burrows B, Niden AH. American emphysema and British bronchitis. A standardized comparative study. Am Rev Respir Dis 1964; 90: 1-13.
24. Baldi S, Miniati M, Bellina CR, et al. Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 585-589.
25. Enright PL. Smoking, lung function, and atherosclerosis in the 5,000 elderly participants of the Cardiovascular Health Study. Am J Geriatr Cardiol 1994; 3: 35-38.
26. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977; 115: 195-205.
27. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001; 17: 946-953.
28. Pizzichini E, Pizzichini MMM, Leigh R, Djukanovic R, Sterk PJ. Safety of sputum induction. Eur Respir J 2002; 20: Suppl. 37, 9s-18s.
29. Retamales I, Elliott WM, Meshi B, et al Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164: 469-473.
30. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158: 1277-1285.